Literature DB >> 19935706

Fhit regulates invasion of lung tumor cells.

A Joannes1, A Bonnomet, S Bindels, M Polette, C Gilles, H Burlet, J Cutrona, J-M Zahm, P Birembaut, B Nawrocki-Raby.   

Abstract

In many types of cancers, the fragile histidine triad (Fhit) gene is frequently targeted by genomic alterations leading to a decrease or loss of gene and protein expression. Fhit has been described as a tumor suppressor gene because of its ability to induce apoptosis and to inhibit proliferation of tumor cells. Moreover, several studies have shown a correlation between the lack of Fhit expression and tumor aggressiveness, thus suggesting that Fhit could be involved in tumor progression. In this study, we explored the potential role of Fhit during tumor cell invasion. We first showed that a low Fhit expression is associated with in vivo and in vitro invasiveness of tumor cells. Then, we showed that Fhit overexpression in Fhit-negative highly invasive NCI-H1299 cells by transfection of Fhit cDNA and Fhit inhibition in Fhit-positive poorly invasive HBE4-E6/E7 cells by transfection of Fhit small interfering RNA induce, respectively, a decrease and an increase in migratory/invasive capacities. These changes in cell behavior were associated with a reorganization of tight and adherens junction molecules and a regulation of matrix metalloproteinase and vimentin expression. These results show that Fhit controls the invasive phenotype of lung tumor cells by regulating the expression of genes associated with epithelial-mesenchymal transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19935706     DOI: 10.1038/onc.2009.418

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.

Authors:  Jennifer A Boylston; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Characterization of the role of Fhit in suppression of DNA damage.

Authors:  Joshua C Saldivar; Jessica Bene; Seyed Ali Hosseini; Satoshi Miuma; Susan Horton; Nyla A Heerema; Kay Huebner
Journal:  Adv Biol Regul       Date:  2012-10-11

Review 3.  The FHIT gene product: tumor suppressor and genome "caretaker".

Authors:  Catherine E Waters; Joshua C Saldivar; Seyed Ali Hosseini; Kay Huebner
Journal:  Cell Mol Life Sci       Date:  2014-10-05       Impact factor: 9.261

4.  Tanshinones induce tumor cell apoptosis via directly targeting FHIT.

Authors:  Xianglian Zhou; Yuting Pan; Yue Wang; Bojun Wang; Yu Yan; Yi Qu; Xisong Ke
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

5.  FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs.

Authors:  Sung-Suk Suh; Ji Young Yoo; Ri Cui; Balveen Kaur; Kay Huebner; Taek-Kyun Lee; Rami I Aqeilan; Carlo M Croce
Journal:  PLoS Genet       Date:  2014-10-23       Impact factor: 5.917

6.  A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.

Authors:  Eugenio Gaudio; Francesco Paduano; Apollinaire Ngankeu; Francesco Ortuso; Francesca Lovat; Sandra Pinton; Sabrina D'Agostino; Nicola Zanesi; Rami I Aqeilan; Pietro Campiglia; Ettore Novellino; Stefano Alcaro; Carlo M Croce; Francesco Trapasso
Journal:  Oncotarget       Date:  2016-05-24

7.  Initiation of genome instability and preneoplastic processes through loss of Fhit expression.

Authors:  Joshua C Saldivar; Satoshi Miuma; Jessica Bene; Seyed Ali Hosseini; Hidetaka Shibata; Jin Sun; Linda J Wheeler; Christopher K Mathews; Kay Huebner
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

8.  Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.

Authors:  Hao Zuo; Grace P W Chan; Jing Zhu; Wendy W S Yeung; Anthony S L Chan; Hermann Ammer; Yung H Wong
Journal:  Cell Commun Signal       Date:  2013-08-15       Impact factor: 5.712

9.  FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.

Authors:  Svenja Dannewitz Prosseda; Xuefei Tian; Kazuya Kuramoto; Mario Boehm; Deepti Sudheendra; Kazuya Miyagawa; Fan Zhang; David Solow-Cordero; Joshua C Saldivar; Eric D Austin; James E Loyd; Lisa Wheeler; Adam Andruska; Michele Donato; Lingli Wang; Kay Huebner; Ross J Metzger; Purvesh Khatri; Edda Spiekerkoetter
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 30.528

10.  Association of activated Gαq to the tumor suppressor Fhit is enhanced by phospholipase Cβ.

Authors:  Hao Zuo; Yung H Wong
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.